Missouri Senate Bill 514 “Modifying Provisions Related To Health Care” Bill Summary

On July 11, 2019, the Missouri Senate passed Senate Bill Number 514 of 2019-2020. The bill modifies provisions related to health care, including the establishment of a "task force on substance abuse prevention and treatment." The bill also created provisions that prohibits prior authorization and annual and lifetime limits for all FDA-approved medications (Methadone, Buprenorphine, and Naltrexone) for substance use disorder (SUD) in commercial insurance plans, and requires the state Medicaid plan to have all the FDA-approved medications on the preferred drug list and requires that all treatment programs disclose which medications they offer . . .